Key facts
- This page summarizes Gary Ingenito's Form 4 filing for CATALYST PHARMACEUTICALS, INC. (CPRX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Jun 2024, 17:00.
Gary Ingenito - 05 Jun 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)
- Reporting relationship
- Chief Med. & Reg. Officer
- Issuer ticker
- CPRX
- Reported as of
- 05 Jun 2024
- Net transaction value
- -$972,000
- SEC form
- 4
- Accepted by SEC
- 07 Jun 2024, 17:00:08 UTC
- Prior SEC filing
- 16 Feb 2024
- Next SEC filing
- 13 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gary Ingenito
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gary Ingenito filed Form 4 for CATALYST PHARMACEUTICALS, INC. (CPRX) on 07 Jun 2024.
Change
- Previous filing in this sequence was filed on 16 Feb 2024.
- Current net transaction value: -$972,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPRX
transaction
Common stock, par value $0.001 per share
Options Exercise
- Transaction value
- $320,800
- Shares
- +80,000
- Change %
- +156%
- Price
- $4.01
- Shares after
- 131,391
- Date
- 05 Jun 2024
- Ownership
- Direct
CPRX
transaction
Common stock, par value $0.001 per share
Sale
- Transaction value
- $1,292,800
- Shares
- -80,000
- Change %
- -61%
- Price
- $16.16
- Shares after
- 51,391
- Date
- 05 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPRX
transaction
Derivative
Options to purchase common stock
Options Exercise
- Transaction value
- $0
- Shares
- -80,000
- Change %
- -7.1%
- Price
- $0.000000
- Shares after
- 1,050,575
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $4.01
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Dr. Ingenito sold the shares on the open market to for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company.
Footnote F2
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.11 to $16.27 per share.
Footnote F3
Options vested in three annual tranches beginning on January 2, 2019.